IL1A and breast carcinoma: 2016 the SUCCESS Study group reported that in pre-therapy primary breast cancer soluble IL-1α was associated with CTC presence in peripheral blood but not within the lymphatic-system indicating IL-1α might suit as a marker for lymphatic cancer invasion.